Using cutting-edge techniques, researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have visualized the structure of a receptor targeted by an anti-cancer immunotherapy. The finding may help scientists improve this type of cancer treatment.
Using an innovative new imaging technique, researchers at Weill Cornell Medicine have revealed the inner workings of a family of light-sensing molecules in unprecedented detail and speed.
The Anti-Racism Curriculum Committee at Weill Cornell Medicine is charged with reinvigorating the curriculum to ensure that medical students gain a firm understanding of how social, economic and policy factors influence health outcomes.
Meiogenix, a next-generation technology startup that helps agricultural crops find their own genetic solutions, via chromosome editing, has joined Cornell’s McGovern Center incubator.
Researchers analyzed the Omicron wave in Qatar last winter, comparing prior infections, vaccine immunity and combinations thereof among more than 100,000 Omicron-infected and non-infected individuals.
Victoria Beard, professor of city and regional planning at Cornell University and expert on how planners need to address urban inequality and poverty, is available for interviews about the long-standing infrastructure problems compounding India’s management of COVID-19.
The 2021 Global and Public Health Experiential Learning Symposium featured projects aimed at improving access to public health everywhere from Tompkins County to Tanzania.
A multidisciplinary team of Weill Cornell Medicine researchers has received a five-year $5.7 million grant from the National Cancer Institute at the National Institutes of Health to fund a center aimed at developing messenger RNA vaccines to deter cancer development in at-risk groups.
